Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2023 Filed Apr 10, 2023 14:54 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009813 · rdgdoc.xml · derivative · entry 4 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,852 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 20225; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 20225; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:54 UTC |
Custer Matthew KeithDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009813 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,886 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 2025; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 2025; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:54 UTC |
Custer Matthew KeithDirector · President and CEO
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009813 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,706 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:54 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009813 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · derivative · entry 5 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,496 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC |
Cysewski Gerald RChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,530 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC |
Cysewski Gerald RChief Scientific Officer
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,417 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 15:32 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 8,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009262 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 508,370 F1 · shares: To reduce the Company's ongoing cash expenses, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his or her quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the third fiscal quarter. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 15:29 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 9,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009260 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,126 F1 · acquired: To reduce the Company's ongoing cash expenses, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his or her quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the third fiscal quarter. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:38 UTC |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 13,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021686 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,455 F1 · balance_after: Since the date of the reporting person's last ownership report, he has transferred 13,445 shares of Cyanotech common stock to his ex-wife pursuant to a domestic relations order for no consideration. The reporting person no longer reports as beneficially owned any securities owned by the ex-wife. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:27 UTC |
McElwee Angela MayDirector
|
GrantCyanotech Corporation Common Stock | 13,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021682 · rdgdoc.xml · nonDerivative · entry 1 McElwee Angela May · CIK 0001893489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,061 Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:24 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 13,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021678 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,005 Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:22 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 13,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021676 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,456 Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:19 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 12,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021674 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 499,819 Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:03 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018417 · rdgdoc.xml · derivative · entry 4 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,942 Underlying: Common Stock · 402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 1,502 shares on July 29, 2024; and 1,502 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 1,502 shares on July 29, 2024; and 1,502 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:03 UTC |
Nordin Amy BethVP, HR, Secretary
|
Tax withholdingCommon Stock | 151 | $3.15 | $475.65 |
DisclosureSEC source: 0001437749-22-018417 · rdgdoc.xml · nonDerivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,552 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 402 shares of stock, the Company withheld a total of 151 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:03 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018417 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:00 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionRestricted Stock Units · Derivative | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018411 · rdgdoc.xml · derivative · entry 4 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,670 Underlying: Common Stock · 498 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 1,379 shares on July 30, 2024; and 1,380 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 1,379 shares on July 30, 2024; and 1,380 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:00 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Tax withholdingCommon Stock | 187 | $3.15 | $589.05 |
DisclosureSEC source: 0001437749-22-018411 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,791 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 498 shares of stock, the Company withheld a total of 187 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 16:00 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018411 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:56 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 565 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018405 · rdgdoc.xml · derivative · entry 5 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523 Underlying: Common Stock · 565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 1,641 shares on July 30, 2024; and 1,642 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 1,641 shares on July 30, 2024; and 1,642 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:56 UTC |
Jensen GlennVP, Operations
|
Tax withholdingCommon Stock | 213 | $3.15 | $670.95 |
DisclosureSEC source: 0001437749-22-018405 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,164 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 565 shares of stock, the Company withheld a total of 213 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:56 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 565 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018405 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · derivative · entry 5 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,430 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC |
Cysewski Gerald RChief Scientific Officer
|
Tax withholdingCommon Stock | 251 | $3.15 | $790.65 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,396 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 666 shares of stock, the Company withheld a total of 251 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:51 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018395 · rdgdoc.xml · derivative · entry 4 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,786 Underlying: Common Stock · 529 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 2,074 shares on July 29, 2024 and 2,075 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 2,074 shares on July 29, 2024 and 2,075 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:51 UTC |
Custer Matthew KeithDirector · President and CEO
|
Tax withholdingCommon Stock | 199 | $3.15 | $626.85 |
DisclosureSEC source: 0001437749-22-018395 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 529 shares of stock, the Company withheld a total of 199 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:51 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018395 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 16:06 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
GrantRestricted Stock Units · Derivative | 5,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018421 · rdgdoc.xml · derivative · entry 1 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,075 Underlying: Common Stock · 5,041 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,680 shares on July 29, 2023; 1,680 shares on July 29, 2024; and 1,681 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,680 shares on July 29, 2023; 1,680 shares on July 29, 2024; and 1,681 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 16:03 UTC |
Nordin Amy BethVP, HR, Secretary
|
GrantRestricted Stock Units · Derivative | 4,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018417 · rdgdoc.xml · derivative · entry 3 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,344 Underlying: Common Stock · 4,505 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 402 shares on July 30, 2022; 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 1,502 shares on July 29, 2024; and 1,502 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 402 shares on July 30, 2022; 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 1,502 shares on July 29, 2024; and 1,502 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 16:00 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
GrantRestricted Stock Units · Derivative | 4,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018411 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,168 Underlying: Common Stock · 4,138 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 498 shares on July 30, 2022; 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 1,379 shares on July 30, 2024; and 1,380 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 498 shares on July 30, 2022; 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 1,379 shares on July 30, 2024; and 1,380 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 15:58 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
GrantRestricted Stock Units · Derivative | 5,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018407 · rdgdoc.xml · derivative · entry 1 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,241 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; and 1,747 shares each on July 29, 2023, July 29, 2024 and July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; and 1,747 shares each on July 29, 2023, July 29, 2024 and July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 15:56 UTC |
Jensen GlennVP, Operations
|
GrantRestricted Stock Units · Derivative | 4,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018405 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,088 Underlying: Common Stock · 4,924 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 565 shares on July 30, 2022; 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 1,641 shares on July 30, 2024; and 1,642 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 565 shares on July 30, 2022; 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 1,641 shares on July 30, 2024; and 1,642 shares on July 30, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 15:53 UTC |
Cysewski Gerald RChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 4,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,096 Underlying: Common Stock · 4,729 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 15:51 UTC |
Custer Matthew KeithDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 6,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018395 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,315 Underlying: Common Stock · 6,223 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 529 shares on July 30, 2022; 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 2,074 shares on July 29, 2024 and 2,075 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 529 shares on July 30, 2022; 34 shares on April 6, 2023; 2,074 shares on July 29, 2023; 529 shares on July 30, 2023; 2,074 shares on July 29, 2024 and 2,075 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 16:55 UTC |
Custer Matthew KeithDirector · President and CEO
|
GrantCyanotech common stock options · Derivative | 50,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001437749-22-015622 · rdgdoc.xml · derivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Cyanotech common stock · 50,000 shares Expires 2032-06-21 F1 · derivative.exercise_date: The stock options shall vest as to 16,666 shares on June 21, 2023, 16,667 shares on June 21, 2024 and 16,667 shares on June 21, 2025, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:56 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008591 · rdgdoc.xml · derivative · entry 3 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023, subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023, subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:56 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Tax withholdingCommon Stock | 14 | $3.03 | $42.42 |
DisclosureSEC source: 0001437749-22-008591 · rdgdoc.xml · nonDerivative · entry 2 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19 F2 · kind: No stock was sold. On April 6, 2022, in connection with the vesting of 33 shares of stock, the Company withheld a total of 14 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:56 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008591 · rdgdoc.xml · nonDerivative · entry 1 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:53 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008587 · rdgdoc.xml · derivative · entry 3 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 839 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 402 shares at July 30, 2022; 34 shares on April 6, 2023; and 403 shares at July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 402 shares at July 30, 2022; 34 shares on April 6, 2023; and 403 shares at July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:53 UTC |
Nordin Amy BethVP, HR, Secretary
|
Tax withholdingCommon Stock | 13 | $3.03 | $39.39 |
DisclosureSEC source: 0001437749-22-008587 · rdgdoc.xml · nonDerivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 F2 · kind: No stock was sold. On April 6, 2022, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:53 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008587 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:44 UTC |
Custer Matthew KeithPresident
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008583 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 529 shares on July 30, 2022; 34 shares on April 6, 2023; and 529 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 529 shares on July 30, 2022; 34 shares on April 6, 2023; and 529 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:44 UTC |
Custer Matthew KeithPresident
|
Tax withholdingCommon Stock | 13 | $3.03 | $39.39 |
DisclosureSEC source: 0001437749-22-008583 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355 F2 · kind: No stock was sold. On April 6, 2022, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:44 UTC |
Custer Matthew KeithPresident
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008583 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:49 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008585 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 498 shares on July 30, 2022; 34 shares on April 6, 2023; and 498 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 498 shares on July 30, 2022; 34 shares on April 6, 2023; and 498 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:49 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Tax withholdingCommon Stock | 13 | $3.03 | $39.39 |
DisclosureSEC source: 0001437749-22-008585 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,480 F2 · kind: No stock was sold. On April 6, 2022, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:49 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008585 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.